by Paul McIntosh | Nov 10, 2026 | 2026, Press Releases
Prestigious U.S professional recognition marks a major milestone for the innovative, scientifically developed toenail repair and recovery product Aberdeen, U.K – 10th November 2026. – NovaBiotics Consumer Health Ltd, a UK-based innovator in scientifically developed...
by Paul McIntosh | May 8, 2025 | 2025, Press Releases
Tinexyl® PRO, marketed by NovaBiotics Consumer Health Ltd and developed by the biotechnology company NovaBiotics, is a first-of-its-kind conditioning product for toenails, only available through UK podiatrists and foot health practitioners. Its unique, proprietary...
by Paul McIntosh | Mar 24, 2025 | 2025, Press Releases
On world TB Day 2025, NovaBiotics Ltd (NovaBiotics) and Liverpool School of Tropical Medicine (LSTM) announce that they are working together to investigate the use of oral cysteamine bitartrate in the treatment of mycobacterial disease, including tuberculosis (TB)....
by Paul McIntosh | Jan 28, 2025 | 2025, Press Releases
The Institute of Podiatrists are delighted to announce their endorsement of Tinexyl PRO. Our Medicines and Procedures Panel (MaPP) were invited to assist with the product review of Tinexyl PRO over a year ago. During this time MaPP have played an active role in...
by Paul McIntosh | Oct 8, 2024 | 2024, Press Releases
NovaBiotics Consumer Health Limited (“NCH”), a division of NovaBiotics Limited (“NovaBiotics” or “the Company”), today announced that it has entered into a distribution agreement with Brand Creations Limited (“BCL, for the rights to commercialise and distribute...
by Paul McIntosh | Sep 6, 2023 | 2023, Press Releases
ABERDEEN 6 SEPTEMBER 2023. NovaBiotics, the clinical-stage biotechnology company announces the appointment of Dr Trevor Phillips to its board as Non-Executive Director. Trevor is a biotechnology leader who previously held board and C-level roles in pharma and Biotech...
Recent Comments